News
Public Symposium on Superbugs: Evolutionary Insights from the PDB
09/14 
Antimicrobial resistance constitutes a global public health emergency. Most antibiotics target bacterial proteins that have no counterparts in human cells. However, as antibacterial drugs continue to be misused and overused, development of resistance to these agents is accelerating worldwide. Drug resistant bacteria, or “superbugs,” kill tens of thousands in the U.S. annually. Unless current trends are reversed, this number will increase ten-fold by 2050, transforming how we approach cancer chemotherapy, routine surgery, childbirth, etc. Professor Burley will discuss how the “superbugs” came about and what we can do to combat them.
Join RCSB PDB Director Stephen Burley for a special presentation at the Chancellor's Colloquium on September 17, 2018 at Rutgers University in Piscataway, NJ. Register now.
